Drug Type Small molecule drug |
Synonyms PB 542, PB542 |
Target |
Action agonists |
Mechanism AHR agonists(Aryl hydrocarbon receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft vs Host Disease | Preclinical | South Korea | 30 Sep 2024 | |
| Inflammatory Bowel Diseases | Preclinical | South Korea | 30 Sep 2024 | |
| Psoriasis | Preclinical | South Korea | 30 Sep 2024 |





